Lawrence S. Melvin

Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.

L. Melvin, D. R. Compton, B. Martin, 1994, The Journal of pharmacology and experimental therapeutics.

Determination and characterization of a cannabinoid receptor in rat brain.

A. Howlett, W. Devane, F. A. Dysarz, 1988, Molecular pharmacology.

Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

K. Rice, M. Johnson, L. Melvin, 1993, The Journal of pharmacology and experimental therapeutics.

Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.

A. Howlett, M. Johnson, L. Melvin, 1993, Molecular pharmacology.

Selective and Potent Analgetics Derived from Cannabinoids

M. Johnson, A. Weissman, J. Bindra, 1981, Journal of clinical pharmacology.

Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics.

M. Johnson, L. Melvin, A. Weissman, 1985, European journal of pharmacology.